← Latest papers
📄 other

Adenylosuccinate acts as a novel pro-angiogenic factor

This study identifies adenylosuccinate (AdSucc) as a novel pro-angiogenic signaling molecule that accumulates during ischemia and promotes blood vessel formation both in vivo and in vitro, potentially serving as an adaptive mechanism to low-energy conditions.

Original authors: Brennon Schofield, Drew Seeger, Derek Besch, Peddanna Kotha, Svetlana Golovko, Bryon Grove, Anahita Mansouripour, Meredith Parmer, Shahram Solaymani-Mohammadi, Mikhail Golovko

Published 2026-07-27
📖 5 min read🧠 Deep dive

Original authors: Brennon Schofield, Drew Seeger, Derek Besch, Peddanna Kotha, Svetlana Golovko, Bryon Grove, Anahita Mansouripour, Meredith Parmer, Shahram Solaymani-Mohammadi, Mikhail Golovko

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your body is a bustling city, and its blood vessels are the roads that deliver fuel (oxygen and nutrients) to every neighborhood. When a part of the city gets damaged—like when a stroke hits the brain—some roads get blocked, and the neighborhoods start to starve. To fix this, the city needs to build new roads quickly. This process is called angiogenesis, which is just a fancy word for "growing new blood vessels." Scientists have been trying to figure out exactly what signals tell the body to start this construction project, especially when the brain is in trouble and running low on energy. Usually, we think of the body using complex chemical messengers to say, "Hey, we need more roads here!" But what if the body uses a simple, unexpected chemical that we didn't realize was a construction foreman all along?

This paper investigates a specific chemical called adenylosuccinate (or AdSucc for short). Normally, AdSucc is just a stepping stone in the body's energy factory, helping to make fuel. However, the researchers noticed something strange: when the brain suffers from a lack of blood flow (ischemia), the amount of AdSucc skyrockets—jumping up 77 times higher than normal. For a long time, scientists thought this huge spike was just a side effect of the body trying to keep its energy levels up. But this team wondered: What if this chemical isn't just a byproduct, but actually a signal telling the body to grow new blood vessels to fix the damage? They set out to test if AdSucc could act as a "go" signal for building new roads in the brain.

The Discovery: A Chemical Construction Foreman

The researchers decided to play detective in two different ways: first, inside a living mouse, and second, in a petri dish with human cells.

The Mouse Experiment: Building Roads in a Test Tube
First, they used a clever trick called a "angioreactor." Imagine tiny, sealed silicone tubes filled with a jelly-like substance. They planted these tubes under the skin of mice. Some tubes were filled with plain jelly (the control), while others were filled with jelly mixed with AdSucc. They waited ten days to see what happened.

The results were exciting. The tubes with AdSucc were packed with 1.8 times more blood vessel cells than the plain ones. To make sure these weren't just empty tubes, they injected a special blue dye into the mice's blood. This dye only stays inside healthy, functioning blood vessels. The AdSucc tubes turned out to be 2.9 times fuller with the blue dye, proving that not only were there more cells, but they were forming actual, working roads that could carry blood.

The "Not a Byproduct" Test
Here is where the scientists got really careful. They knew that AdSucc breaks down into other chemicals, like AMP and adenosine. Maybe AdSucc wasn't doing the work; maybe its broken-down pieces were the real heroes? To find out, they checked the chemistry inside the tubes over time. They found that AdSucc disappeared quickly, but the broken-down pieces didn't seem to be the cause. When they tested those broken-down pieces (AMP and adenosine) on their own in the amounts found in the experiment, they did not cause any new blood vessels to grow. This was a big clue: it wasn't the leftovers; it was the AdSucc itself doing the construction work.

The Human Cell Test: Building a Web
Next, they wanted to see if this worked on human cells. They took human blood vessel cells (HUVECs) and put them on a special gel that encourages them to connect and form tube-like structures, mimicking a tiny network of capillaries. When they added AdSucc, the cells went into overdrive. They didn't just grow; they built a much more complex and mature web. The number of connections (junctions) between the tubes jumped by 2.2 times, and the total area covered by the mesh increased by 2.6 times. Interestingly, the AdSucc seemed to work best on cells that were a bit stressed or just starting out, which makes sense because this is exactly the kind of environment found in a damaged brain.

The "How" Question: The cAMP Signal
Finally, the team wanted to know how AdSucc tells the cells to build. They looked at a chemical messenger inside the cells called cAMP, which is known to help with growth and repair. When they treated the cells with AdSucc, the levels of cAMP shot up by nearly 2 times. This suggests that AdSucc acts like a key, unlocking a signal inside the cell that says, "Start building!"

What This Means

The paper concludes that AdSucc is likely a new, important signal the body uses when it's in trouble. When the brain is starved of oxygen, AdSucc levels go up, and this chemical seems to tell the blood vessels to grow and repair the damage. The researchers are careful to say that while their data is strong in mice and human cells, more studies are needed to confirm exactly how this works in a real human stroke recovery. But the idea is clear: AdSucc isn't just a waste product of energy; it might be a vital repair crew leader, stepping up when the body needs it most.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →